Improving the treatment of Clostridium difficile-associated disease: where should we start?
Pepin
Jacques
J
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy*; D006801:Humans
D000900:Anti-Bacterial Agents